Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Sara M Tolaney, Hao Guo, +23 authors, Sonia Pernas, William T Barry, Deborah A Dillon, Lauren Ritterhouse, Bryan P Schneider, Fei Shen, Kit Fuhrman, Michele Baltay, Chau T Dang, Denise A Yardley, Beverly Moy, P Kelly Marcom, Kathy S Albain, Hope S Rugo, Mathew J Ellis, Iuliana Shapira, Antonio C Wolff, Lisa A Carey, Beth Overmoyer, Ann H Partridge, Clifford A Hudis, Ian E Krop, Harold J Burstein, Eric P Winer. less
J Clin Oncol, 2019 Apr 03; 37(22). PMID: 30939096 Free PMC article.
Highly Cited.
|
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park, William Hiller, Edwin R Fisher, D Lawrence Wickerham, John Bryant, Norman Wolmark. less
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
|
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
Sara A Hurvitz, Miguel Martin, +18 authors, Kyung Hae Jung, Chiun-Sheng Huang, Nadia Harbeck, Vicente Valero, Daniil Stroyakovskiy, Hans Wildiers, Mario Campone, Jean-François Boileau, Peter A Fasching, Karen Afenjar, Gonzalo Spera, Vanesa Lopez-Valverde, Chunyan Song, Peter Trask, Thomas Boulet, Joseph A Sparano, W Fraser Symmans, Alastair M Thompson, Dennis Slamon. less
J Clin Oncol, 2019 Jun 04; 37(25). PMID: 31157583 Free PMC article.
|
Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction.
Chirag Shah, Douglas Arthur, +2 authors, Justin Riutta, Pat Whitworth, Frank A Vicini. less
Breast J, 2012 Jul 05; 18(4). PMID: 22759095
Review.
|
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Benjamin O Anderson, +32 authors, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H Allison, Sarah L Blair, Harold J Burstein, Chau Dang, Anthony D Elias, Sharon H Giordano, Matthew P Goetz, Lori J Goldstein, Steven J Isakoff, Jairam Krishnamurthy, Janice Lyons, P Kelly Marcom, Jennifer Matro, Ingrid A Mayer, Meena S Moran, Joanne Mortimer, Ruth M O'Regan, Sameer A Patel, Lori J Pierce, Hope S Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Erica M Stringer-Reasor, Melinda L Telli, John H Ward, Jessica S Young, Jennifer L Burns, Rashmi Kumar. less
J Natl Compr Canc Netw, 2020 Apr 08; 18(4). PMID: 32259783
|
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, +18 authors, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim, Yasuhiro Yanagita, Shinji Ohno, Shintaro Takao, Kenjiro Aogi, Hiroji Iwata, Joon Jeong, Aeree Kim, Kyong-Hwa Park, Hironobu Sasano, Yasuo Ohashi, Masakazu Toi. less
N Engl J Med, 2017 Jun 01; 376(22). PMID: 28564564
Highly Cited.
|
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
A Murray Brunt, Duncan Wheatley, +13 authors, John Yarnold, Navita Somaiah, Stephen Kelly, Adrian Harnett, Charlotte Coles, Andrew Goodman, Amit Bahl, Mark Churn, Rada Zotova, Mark Sydenham, Clare L Griffin, James P Morden, Judith M Bliss, FAST-Forward Trial Management Group. less
Radiother Oncol, 2016 Apr 06; 120(1). PMID: 27046390 Free PMC article.
|
Increase in response rate by prolonged treatment with neoadjuvant letrozole.
J Michael Dixon, Lorna Renshaw, +6 authors, E Jane Macaskill, Oliver Young, Juliette Murray, David Cameron, Gillian R Kerr, Dean B Evans, William R Miller. less
Breast Cancer Res Treat, 2008 Feb 12; 113(1). PMID: 18264759
|
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Harry Bartelink, Philippe Maingon, +20 authors, Philip Poortmans, Caroline Weltens, Alain Fourquet, Jos Jager, Dominic Schinagl, Bing Oei, Carla Rodenhuis, Jean-Claude Horiot, Henk Struikmans, Erik Van Limbergen, Youlia Kirova, Paula Elkhuizen, Rudolf Bongartz, Raymond Miralbell, David Morgan, Jean-Bernard Dubois, Vincent Remouchamps, René-Olivier Mirimanoff, Sandra Collette, Laurence Collette, European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. less
Lancet Oncol, 2014 Dec 17; 16(1). PMID: 25500422
Highly Cited.
|
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), S Darby, +13 authors, P McGale, C Correa, C Taylor, R Arriagada, M Clarke, D Cutter, C Davies, M Ewertz, J Godwin, R Gray, L Pierce, T Whelan, Y Wang, R Peto. less
Lancet, 2011 Oct 25; 378(9804). PMID: 22019144 Free PMC article.
Highly Cited. Review.
|
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
Matthew J Ellis, Vera J Suman, +28 authors, Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Chad J Creighton, Katherine DeSchryver, Erika Crouch, Amy Brink, Mark Watson, Jingqin Luo, Yu Tao, Michael Barnes, Mitchell Dowsett, G Thomas Budd, Eric Winer, Paula Silverman, Laura Esserman, Lisa Carey, Cynthia X Ma, Gary Unzeitig, Timothy Pluard, Pat Whitworth, Gildy Babiera, J Michael Guenther, Zoneddy Dayao, David Ota, Marilyn Leitch, John A Olson, D Craig Allred, Kelly Hunt. less
J Clin Oncol, 2017 Jan 04; 35(10). PMID: 28045625 Free PMC article.
Highly Cited.
|
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Benjamin D Smith, Jennifer R Bellon, +13 authors, Rachel Blitzblau, Gary Freedman, Bruce Haffty, Carol Hahn, Francine Halberg, Karen Hoffman, Kathleen Horst, Jean Moran, Caroline Patton, Jane Perlmutter, Laura Warren, Timothy Whelan, Jean L Wright, Reshma Jagsi. less
Pract Radiat Oncol, 2018 Mar 17; 8(3). PMID: 29545124
Highly Cited.
|
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
Per Karlsson, Bernard F Cole, +8 authors, Marco Colleoni, Mario Roncadin, Boon H Chua, Elizabeth Murray, Karen N Price, Monica Castiglione-Gertsch, Aron Goldhirsch, Günther Gruber, International Breast Cancer Study Group. less
Int J Radiat Oncol Biol Phys, 2010 Aug 24; 80(2). PMID: 20729007 Free PMC article.
|
First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.
Anthony E Dragun, Nicholas J Ajkay, +8 authors, Elizabeth C Riley, Teresa L Roberts, Jianmin Pan, Shesh N Rai, Dharamvir Jain, Amy R Quillo, Charles R Scoggins, Kelly M McMasters, Shiao Y Woo. less
Int J Radiat Oncol Biol Phys, 2017 Jun 06; 98(3). PMID: 28581400
|
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
Davide Mauri, Konstantinos Kamposioras, +3 authors, Maria Tolia, Filippo Alongi, Dimitrios Tzachanis, International Oncology Panel and European Cancer Patient Coalition collaborators. less
Lancet Oncol, 2020 May 16; 21(6). PMID: 32410877 Free PMC article.
|
Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic.
Jonathan M Marron, Steven Joffe, +2 authors, Reshma Jagsi, Rebecca A Spence, Fay J Hlubocky. less
J Clin Oncol, 2020 Apr 29; 38(19). PMID: 32343643
|
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Adrian Murray Brunt, Joanne S Haviland, +21 authors, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Carolyn Morris, Zohal Nabi, Elinor Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M Bliss, John R Yarnold, FAST-Forward Trial Management Group. less
Lancet, 2020 Jun 26; 395(10237). PMID: 32580883 Free PMC article.
|
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Sibylle Loibl, Joyce O'Shaughnessy, +16 authors, Michael Untch, William M Sikov, Hope S Rugo, Mark D McKee, Jens Huober, Mehra Golshan, Gunter von Minckwitz, David Maag, Danielle Sullivan, Norman Wolmark, Kristi McIntyre, Jose J Ponce Lorenzo, Otto Metzger Filho, Priya Rastogi, W Fraser Symmans, Xuan Liu, Charles E Geyer. less
Lancet Oncol, 2018 Mar 05; 19(4). PMID: 29501363
Highly Cited.
|
Psychosocial outcomes of breast cancer therapies: lumpectomy versus mastectomy.
D K Wellisch, R DiMatteo, +6 authors, M Silverstein, J Landsverk, R Hoffman, J Waisman, N Handel, E Waisman-Smith, W Schain. less
Psychosomatics, 1989 Jan 01; 30(4). PMID: 2798728
|
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, +58 authors, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu, David E Goldgar, Mary Beth Terry, Matti A Rookus, Douglas F Easton, Antonis C Antoniou, BRCA1 and BRCA2 Cohort Consortium, Lesley McGuffog, D Gareth Evans, Daniel Barrowdale, Debra Frost, Julian Adlard, Kai-Ren Ong, Louise Izatt, Marc Tischkowitz, Ros Eeles, Rosemarie Davidson, Shirley Hodgson, Steve Ellis, Catherine Nogues, Christine Lasset, Dominique Stoppa-Lyonnet, Jean-Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J Hooning, Lizet E van der Kolk, Carolien M Kets, Muriel A Adank, Esther M John, Wendy K Chung, Irene L Andrulis, Melissa Southey, Mary B Daly, Saundra S Buys, Ana Osorio, Christoph Engel, Karin Kast, Rita K Schmutzler, Trinidad Caldes, Anna Jakubowska, Jacques Simard, Michael L Friedlander, Sue-Anne McLachlan, Eva Machackova, Lenka Foretova, Yen Y Tan, Christian F Singer, Edith Olah, Anne-Marie Gerdes, Brita Arver, Håkan Olsson. less
JAMA, 2017 Jun 21; 317(23). PMID: 28632866
Highly Cited.
|
Time interval from breast-conserving surgery to breast irradiation in early stage node-negative breast cancer: 17-year follow-up results and patterns of recurrence.
Olga Vujovic, Edward Yu, +3 authors, Anil Cherian, A Rashid Dar, Larry Stitt, Francisco Perera. less
Int J Radiat Oncol Biol Phys, 2015 Feb 01; 91(2). PMID: 25636757
|
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2015 Jul 28; 386(10001). PMID: 26211827
Highly Cited.
|
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Frank A Vicini, Reena S Cecchini, +24 authors, Julia R White, Douglas W Arthur, Thomas B Julian, Rachel A Rabinovitch, Robert R Kuske, Patricia A Ganz, David S Parda, Michael F Scheier, Kathryn A Winter, Soonmyung Paik, Henry M Kuerer, Laura A Vallow, Lori J Pierce, Eleftherios P Mamounas, Beryl McCormick, Joseph P Costantino, Harry D Bear, Isabelle Germain, Gregory Gustafson, Linda Grossheim, Ivy A Petersen, Richard S Hudes, Walter J Curran, John L Bryant, Norman Wolmark. less
Lancet, 2019 Dec 10; 394(10215). PMID: 31813636 Free PMC article.
|
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.
Bernard Fisher, Jong-Hyeon Jeong, +3 authors, Stewart Anderson, John Bryant, Edwin R Fisher, Norman Wolmark. less
N Engl J Med, 2002 Aug 23; 347(8). PMID: 12192016
Highly Cited.
|
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer.
Vladimir F Semiglazov, Vladislav V Semiglazov, +7 authors, Garik A Dashyan, Elena K Ziltsova, Vadim G Ivanov, Alla A Bozhok, Olga A Melnikova, Ruslan M Paltuev, Alexander Kletzel, Lev M Berstein. less
Cancer, 2007 Jun 01; 110(2). PMID: 17538978
|
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
G Allevi, C Strina, +15 authors, D Andreis, V Zanoni, L Bazzola, S Bonardi, C Foroni, M Milani, M R Cappelletti, F Gussago, S Aguggini, R Giardini, M Martinotti, S B Fox, A L Harris, A Bottini, A Berruti, D Generali. less
Br J Cancer, 2013 Apr 13; 108(8). PMID: 23579222 Free PMC article.
|
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
Timothy J Whelan, Jim A Julian, +19 authors, Tanya S Berrang, Do-Hoon Kim, Isabelle Germain, Alan M Nichol, Mohamed Akra, Sophie Lavertu, Francois Germain, Anthony Fyles, Theresa Trotter, Francisco E Perera, Susan Balkwill, Susan Chafe, Thomas McGowan, Thierry Muanza, Wayne A Beckham, Boon H Chua, Chu Shu Gu, Mark N Levine, Ivo A Olivotto, RAPID Trial Investigators. less
Lancet, 2019 Dec 10; 394(10215). PMID: 31813635
|
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, +32 authors, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne Brain, Sylvain Causeret, Mauro DeLorenzi, Annuska M Glas, Vassilis Golfinopoulos, Theodora Goulioti, Susan Knox, Erika Matos, Bart Meulemans, Peter A Neijenhuis, Ulrike Nitz, Rodolfo Passalacqua, Peter Ravdin, Isabel T Rubio, Mahasti Saghatchian, Tineke J Smilde, Christos Sotiriou, Lisette Stork, Carolyn Straehle, Geraldine Thomas, Alastair M Thompson, Jacobus M van der Hoeven, Peter Vuylsteke, René Bernards, Konstantinos Tryfonidis, Emiel Rutgers, Martine Piccart, MINDACT Investigators. less
N Engl J Med, 2016 Aug 25; 375(8). PMID: 27557300
Highly Cited.
|
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study.
E Alba, L Calvo, +10 authors, J Albanell, J R De la Haba, A Arcusa Lanza, J I Chacon, P Sanchez-Rovira, A Plazaola, J A Lopez Garcia-Asenjo, B Bermejo, E Carrasco, A Lluch, GEICAM. less
Ann Oncol, 2012 Jun 08; 23(12). PMID: 22674146
|
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
Jill R Dietz, Meena S Moran, +16 authors, Steven J Isakoff, Scott H Kurtzman, Shawna C Willey, Harold J Burstein, Richard J Bleicher, Janice A Lyons, Terry Sarantou, Paul L Baron, Randy E Stevens, Susan K Boolbol, Benjamin O Anderson, Lawrence N Shulman, William J Gradishar, Debra L Monticciolo, Donna M Plecha, Heidi Nelson, Katharine A Yao. less
Breast Cancer Res Treat, 2020 Apr 26; 181(3). PMID: 32333293 Free PMC article.
Highly Cited.
|
Patient-physician communication in oncology: past, present, and future.
Walter F Baile, Joann Aaron.
Curr Opin Oncol, 2005 Jun 04; 17(4). PMID: 15933462
Review.
|
The safety of multiple re-excisions after lumpectomy for breast cancer.
Suzanne Coopey, Barbara L Smith, +4 authors, Stephanie Hanson, Julliette Buckley, Kevin S Hughes, Michele Gadd, Michelle C Specht. less
Ann Surg Oncol, 2011 Jun 02; 18(13). PMID: 21630123
|
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
A Schneeweiss, S Chia, +10 authors, T Hickish, V Harvey, A Eniu, R Hegg, C Tausch, J H Seo, Y-F Tsai, J Ratnayake, V McNally, G Ross, J Cortés. less
Ann Oncol, 2013 May 25; 24(9). PMID: 23704196
Highly Cited.
|
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Peter M Ravdin, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, Jeffrey L Berenberg, Jeffrey Abrams, George W Sledge. less
N Engl J Med, 2018 Jun 05; 379(2). PMID: 29860917 Free PMC article.
Highly Cited.
|
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Edith A Perez, John A Olson, JoAnne Zujewski, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Peter Ravdin, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, James N Atkins, Jeffrey L Berenberg, George W Sledge. less
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349 Free PMC article.
Highly Cited.
|
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.
Vikas Mehta, Sanjay Goel, +16 authors, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, Kith Pradhan, Raja Thota, Stan Reissman, Joseph A Sparano, Benjamin A Gartrell, Richard V Smith, Nitin Ohri, Madhur Garg, Andrew D Racine, Shalom Kalnicki, Roman Perez-Soler, Balazs Halmos, Amit Verma. less
Cancer Discov, 2020 May 03; 10(7). PMID: 32357994 Free PMC article.
Highly Cited.
|
Approaching difficult communication tasks in oncology.
Anthony L Back, Robert M Arnold, +2 authors, Walter F Baile, James A Tulsky, Kelly Fryer-Edwards. less
CA Cancer J Clin, 2005 May 14; 55(3). PMID: 15890639
Review.
|
Communication Skills in the Age of COVID-19.
Anthony Back, James A Tulsky, Robert M Arnold.
Ann Intern Med, 2020 Apr 03; 172(11). PMID: 32240282 Free PMC article.
|
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Ian E Smith, Mitch Dowsett, +8 authors, Stephen R Ebbs, J Michael Dixon, Anthony Skene, J-U Blohmer, Susan E Ashley, Stephen Francis, Irene Boeddinghaus, Geraldine Walsh, IMPACT Trialists Group. less
J Clin Oncol, 2005 Jul 07; 23(22). PMID: 15998903
Highly Cited.
|
Determinants and Outcomes of Satisfaction With Healthcare Provider Communication Among Cancer Survivors.
Ashish Rai, Xuesong Han, +2 authors, Zhiyuan Zheng, K Robin Yabroff, Ahmedin Jemal. less
J Natl Compr Canc Netw, 2018 Aug 14; 16(8). PMID: 30099374
|
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Hongchao Pan, Richard Gray, +9 authors, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I Pritchard, Jonas Bergh, Mitch Dowsett, Daniel F Hayes, EBCTCG. less
N Engl J Med, 2017 Nov 09; 377(19). PMID: 29117498 Free PMC article.
Highly Cited.
|
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
William M Sikov, Donald A Berry, +14 authors, Charles M Perou, Baljit Singh, Constance T Cirrincione, Sara M Tolaney, Charles S Kuzma, Timothy J Pluard, George Somlo, Elisa R Port, Mehra Golshan, Jennifer R Bellon, Deborah Collyar, Olwen M Hahn, Lisa A Carey, Clifford A Hudis, Eric P Winer. less
J Clin Oncol, 2014 Aug 06; 33(1). PMID: 25092775 Free PMC article.
Highly Cited.
|
Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy.
Ivo A Olivotto, Mary L Lesperance, +9 authors, Pauline T Truong, Alan Nichol, Tanya Berrang, Scott Tyldesley, François Germain, Caroline Speers, Elaine Wai, Caroline Holloway, Winkle Kwan, Hagen Kennecke. less
J Clin Oncol, 2008 Nov 20; 27(1). PMID: 19018080
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Joanne L Blum, Patrick J Flynn, +19 authors, Greg Yothers, Lina Asmar, Charles E Geyer, Samuel A Jacobs, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Chau T Dang, Henry Leonidas Gómez, Louis Fehrenbacher, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Jong-Hyeon Jeong, Linda H Colangelo, Sandra M Swain, Eleftherios P Mamounas, Stephen E Jones, Norman Wolmark. less
J Clin Oncol, 2017 Apr 12; 35(23). PMID: 28398846 Free PMC article.
Highly Cited.
|
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.
C Palmieri, S Cleator, +19 authors, L S Kilburn, S B Kim, S-H Ahn, M Beresford, G Gong, J Mansi, E Mallon, S Reed, K Mousa, L Fallowfield, M Cheang, J Morden, K Page, D S Guttery, B Rghebi, L Primrose, J A Shaw, A M Thompson, J M Bliss, R C Coombes. less
Breast Cancer Res Treat, 2014 Nov 15; 148(3). PMID: 25395314
|
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
Stephen Jones, Frankie Ann Holmes, +17 authors, Joyce O'Shaughnessy, Joanne L Blum, Svetislava J Vukelja, Kristi J McIntyre, John E Pippen, James H Bordelon, Robert L Kirby, John Sandbach, William J Hyman, Donald A Richards, Robert G Mennel, Kristi A Boehm, Wally G Meyer, Lina Asmar, Daniel Mackey, Stefan Riedel, Hyman Muss, Michael A Savin. less
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204201
Highly Cited.
|
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Hiroji Iwata, Norikazu Masuda, +19 authors, Yutaka Yamamoto, Tomomi Fujisawa, Tatsuya Toyama, Masahiro Kashiwaba, Shoichiro Ohtani, Naruto Taira, Takehiko Sakai, Yoshie Hasegawa, Rikiya Nakamura, Hiromitsu Akabane, Yukiko Shibahara, Hironobu Sasano, Takuhiro Yamaguchi, Kentaro Sakamaki, Helen Bailey, Diana B Cherbavaz, Debbie M Jakubowski, Naoko Sugiyama, Calvin Chao, Yasuo Ohashi. less
Breast Cancer Res Treat, 2018 Sep 23; 173(1). PMID: 30242578 Free PMC article.
|
A Survey on Physical and Mental Distress among Cancer Patients during the COVID-19 Epidemic in Wuhan, China.
Yu Qian, Kun Wu, +9 authors, Hongbin Xu, Dan Bao, Fengming Ran, Wei Wei, Tiancui Cheng, Dingfeng Huang, Xi Lin, Eduardo Bruera, Desheng Hu, Yuan Wu. less
J Palliat Med, 2020 May 16; 23(7). PMID: 32408790
|
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Gunter von Minckwitz, Marion Procter, +16 authors, Evandro de Azambuja, Dimitrios Zardavas, Mark Benyunes, Giuseppe Viale, Thomas Suter, Amal Arahmani, Nathalie Rouchet, Emma Clark, Adam Knott, Istvan Lang, Christelle Levy, Denise A Yardley, Jose Bines, Richard D Gelber, Martine Piccart, Jose Baselga, APHINITY Steering Committee and Investigators. less
N Engl J Med, 2017 Jun 06; 377(2). PMID: 28581356 Free PMC article.
Highly Cited.
|
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Luca Gianni, Tadeusz Pienkowski, +17 authors, Young-Hyuck Im, Ling-Ming Tseng, Mei-Ching Liu, Ana Lluch, Elżbieta Starosławska, Juan de la Haba-Rodriguez, Seock-Ah Im, Jose Luiz Pedrini, Brigitte Poirier, Paolo Morandi, Vladimir Semiglazov, Vichien Srimuninnimit, Giulia Valeria Bianchi, Domenico Magazzù, Virginia McNally, Hannah Douthwaite, Graham Ross, Pinuccia Valagussa. less
Lancet Oncol, 2016 May 18; 17(6). PMID: 27179402
Highly Cited.
|
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.
Akiko Chiba, Tanya L Hoskin, +3 authors, Courtney N Heins, Kelly K Hunt, Elizabeth B Habermann, Judy C Boughey. less
Ann Surg Oncol, 2016 Sep 25; 24(2). PMID: 27663568 Free PMC article.
|
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.
M J Ellis, A Coop, +9 authors, B Singh, L Mauriac, A Llombert-Cussac, F Jänicke, W R Miller, D B Evans, M Dugan, C Brady, E Quebe-Fehling, M Borgs. less
J Clin Oncol, 2001 Sep 18; 19(18). PMID: 11559718
Highly Cited.
|
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
Jennifer R Bellon, Steven E Come, +5 authors, Rebecca S Gelman, I Craig Henderson, Lawrence N Shulman, Barbara J Silver, Jay R Harris, Abram Recht. less
J Clin Oncol, 2005 Mar 19; 23(9). PMID: 15774786
|
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.
W Eiermann, S Paepke, +10 authors, J Appfelstaedt, A Llombart-Cussac, J Eremin, J Vinholes, L Mauriac, M Ellis, M Lassus, H A Chaudri-Ross, M Dugan, M Borgs, Letrozole Neo-Adjuvant Breast Cancer Study Group. less
Ann Oncol, 2002 Feb 02; 12(11). PMID: 11822750
Highly Cited.
|
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.
Catherine L Harper-Wynne, Nigel P M Sacks, +14 authors, Karyn Shenton, Fiona A MacNeill, Paul Sauven, Ian J Laidlaw, Zen Rayter, Stephanie Miall, Angela Howes, Janine Salter, Margaret J Hills, Frances M Lowe, Roger A'Hern, Nazar Nasiri, Debbie Doody, Jhangir Iqbal, Mitchell Dowsett. less
J Clin Oncol, 2002 Feb 15; 20(4). PMID: 11844826
|
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
Luigi Cataliotti, Aman U Buzdar, +5 authors, Shinzaburo Noguchi, Jose Bines, Yuichi Takatsuka, Katarina Petrakova, Pierre Dube, Celia Tosello de Oliveira. less
Cancer, 2006 Apr 07; 106(10). PMID: 16598749
|
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
FAST Trialists group, Rajiv K Agrawal, +23 authors, Abdulla Alhasso, Peter J Barrett-Lee, Judith M Bliss, Peter Bliss, David Bloomfield, Joanna Bowen, A Murray Brunt, Ellen Donovan, Marie Emson, Andrew Goodman, Adrian Harnett, Joanne S Haviland, Ronald Kaggwa, James P Morden, Anne Robinson, Sandra Simmons, Alan Stewart, Mark A Sydenham, Isabel Syndikus, Jean Tremlett, Yat Tsang, Duncan Wheatley, Karen Venables, John R Yarnold. less
Radiother Oncol, 2011 Jul 15; 100(1). PMID: 21752481
|
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
Gunter von Minckwitz, Chiun-Sheng Huang, +27 authors, Max S Mano, Sibylle Loibl, Eleftherios P Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo, Hans H Fischer, William Jacot, Alison K Conlin, Claudia Arce-Salinas, Irene L Wapnir, Christian Jackisch, Michael P DiGiovanna, Peter A Fasching, John P Crown, Pia Wülfing, Zhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H Lam, David Tesarowski, Melanie Smitt, Hannah Douthwaite, Stina M Singel, Charles E Geyer, KATHERINE Investigators. less
N Engl J Med, 2018 Dec 06; 380(7). PMID: 30516102
Highly Cited.
|
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.
Mitch Dowsett, Ivana Sestak, +7 authors, Elena Lopez-Knowles, Kalvinder Sidhu, Anita K Dunbier, J Wayne Cowens, Sean Ferree, James Storhoff, Carl Schaper, Jack Cuzick. less
J Clin Oncol, 2013 Jul 03; 31(22). PMID: 23816962
Highly Cited.
|
Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery.
C Pozo, C S Carver, +6 authors, V Noriega, S D Harris, D S Robinson, A S Ketcham, A Legaspi, F L Moffat, K C Clark. less
J Clin Oncol, 1992 Aug 11; 10(8). PMID: 1634919
|
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, Peter M Ravdin, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, Jeffrey L Berenberg, Jeffrey Abrams, George W Sledge. less
N Engl J Med, 2019 Jun 04; 380(25). PMID: 31157962 Free PMC article.
Highly Cited.
|
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
Lisa A Carey, Donald A Berry, +15 authors, Constance T Cirrincione, William T Barry, Brandelyn N Pitcher, Lyndsay N Harris, David W Ollila, Ian E Krop, Norah Lynn Henry, Douglas J Weckstein, Carey K Anders, Baljit Singh, Katherine A Hoadley, Michael Iglesia, Maggie Chon U Cheang, Charles M Perou, Eric P Winer, Clifford A Hudis. less
J Clin Oncol, 2015 Nov 04; 34(6). PMID: 26527775 Free PMC article.
Highly Cited.
|
Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer.
Katsuhiko Nakatsukasa, Hiroshi Koyama, +14 authors, Yoshimi Oouchi, Seiichi Imanishi, Naruhiko Mizuta, Kouichi Sakaguchi, Yoshifumi Fujita, Ikuya Fujiwara, Tatsuya Kotani, Takayuki Matsuda, Kenichirou Fukuda, Midori Morita, Sadao Kawakami, Yayoi Kadotani, Eiichi Konishi, Akio Yanagisawa, Tetsuya Taguchi. less
Breast Cancer, 2016 Jan 13; 24(1). PMID: 26754092
|
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
Laura M Spring, Arjun Gupta, +5 authors, Kerry L Reynolds, Michele A Gadd, Leif W Ellisen, Steven J Isakoff, Beverly Moy, Aditya Bardia. less
JAMA Oncol, 2016 Jul 02; 2(11). PMID: 27367583 Free PMC article.
Highly Cited. Systematic Review.
|
ACR Appropriateness Criteria® Palpable Breast Masses.
Expert Panel on Breast Imaging:, Linda Moy, +13 authors, Samantha L Heller, Lisa Bailey, Carl D'Orsi, Roberta M DiFlorio, Edward D Green, Anna I Holbrook, Su-Ju Lee, Ana P Lourenco, Martha B Mainiero, Karla A Sepulveda, Priscilla J Slanetz, Sunita Trikha, Monica M Yepes, Mary S Newell. less
J Am Coll Radiol, 2017 May 06; 14(5S). PMID: 28473077
Review.
|
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
Norikazu Masuda, Yasuaki Sagara, +8 authors, Takayuki Kinoshita, Hiroji Iwata, Seigo Nakamura, Yasuhiro Yanagita, Reiki Nishimura, Hirotaka Iwase, Shunji Kamigaki, Hiroyuki Takei, Shinzaburo Noguchi. less
Lancet Oncol, 2012 Jan 24; 13(4). PMID: 22265697
|
Accelerated fractionation with a concurrent boost for early stage breast cancer.
Gary M Freedman, Julia R White, +2 authors, Douglas W Arthur, X Allen Li, Frank A Vicini. less
Radiother Oncol, 2013 Jan 22; 106(1). PMID: 23333014
Review.
|
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.
Candace Correa, Eleanor E Harris, +5 authors, Maria Cristina Leonardi, Benjamin D Smith, Alphonse G Taghian, Alastair M Thompson, Julia White, Jay R Harris. less
Pract Radiat Oncol, 2016 Nov 22; 7(2). PMID: 27866865
Highly Cited.
|
